Edition:
United States

Interleukin Genetics Inc (ILIU.PK)

ILIU.PK on OTC Markets Group

0.00USD
20 Sep 2017
Change (% chg)

-- (--)
Prev Close
$0.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
161,449
52-wk High
$0.20
52-wk Low
$0.00

Chart for

About

Interleukin Genetics, Inc. develops and markets genetic tests for chronic diseases and health-related conditions. The Company operates through the genetic test business segment. The Company's products include PerioPredict genetic test and Inherent Health line of genetic tests. PerioPredict is a genetic risk test that analyzes... (more)
No analyst recommendations are available for .

Overall

Beta: 1.14
Market Cap(Mil.): $0.92
Shares Outstanding(Mil.): 229.47
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 29.78 16.33
EPS (TTM): -- -- --
ROI: -- 6.58 14.66
ROE: -- 10.40 13.99

BRIEF-Interleukin Genetics to wind-up and pursue liquidation plan

* Interleukin Genetics to wind-up and pursue a plan of liquidation

Jul 24 2017

BRIEF-Interleukin Genetics to explore strategic alternatives, reduce workforce

* Interleukin genetics to explore strategic alternatives, reduce workforce

Jul 03 2017

Earnings vs. Estimates